A detailed history of Ci Private Wealth, LLC transactions in Renalytix PLC stock. As of the latest transaction made, Ci Private Wealth, LLC holds 335,514 shares of RNLX stock, worth $50,327. This represents 0.0% of its overall portfolio holdings.

Number of Shares
335,514
Previous 335,514 -0.0%
Holding current value
$50,327
Previous $77,000 9.09%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$0.33 - $1.61 $115 - $563
350 Added 0.1%
335,514 $130,000
Q3 2023

Nov 03, 2023

BUY
$1.51 - $4.01 $165,254 - $438,854
109,440 Added 48.48%
335,164 $536,000
Q2 2023

Aug 10, 2023

BUY
$2.0 - $2.92 $21,800 - $31,828
10,900 Added 5.07%
225,724 $659,000
Q1 2023

May 15, 2023

BUY
$1.93 - $3.72 $51,338 - $98,952
26,600 Added 14.13%
214,824 $519,000
Q4 2022

Feb 15, 2023

BUY
$1.06 - $2.21 $199,517 - $415,975
188,224 New
188,224 $351,000

Others Institutions Holding RNLX

About Renalytix plc


  • Ticker RNLX
  • Exchange OTC
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 37,445,900
  • Market Cap $5.62M
  • Description
  • Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...
More about RNLX
Track This Portfolio

Track Ci Private Wealth, LLC Portfolio

Follow Ci Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ci Private Wealth, LLC with notifications on news.